Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 2/2013

01-04-2013 | RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

Disease-Specific Quality-of-Life Questionnaires in Rhinitis and Rhinosinusitis: Review and Evaluation

Authors: Dirk A. E. Dietz de Loos, Christine L. Segboer, Artur Gevorgyan, Wytske J. Fokkens

Published in: Current Allergy and Asthma Reports | Issue 2/2013

Login to get access

Abstract

Quality of life (QoL) measurements are the best approximation of the burden of disease for the patient. Patient-reported outcome measurements (PROMs) estimate health-related quality of life (HRQoL). PROMs can be generic or disease-specific. Generic PROMs allow comparisons between different diseases but can be relatively insensitive for measuring changes within a disease. Recommended QoL questionnaires in allergic rhinitis and rhinoconjunctivitis are the RQLQ (or adapted versions), in chronic rhinosinusitis, the SNOT-22 or RSOM-31, and in acute rhinosinusitis, the modified SNOT-16. PROMs can be used both for daily clinical work and for research. In daily practice, a quick evaluation of the questionnaire directly indicates how the patient is doing. It makes sure that symptoms important for the patient are not overlooked and, during the consultation, the physician can elaborate on specific aspects of the symptomatology. It is important, especially in research, to realize that disease-specific questionnaires are only validated for specific diseases and are not automatically valid for other diseases.
Literature
1.
Hellings PW, Scadding G, Alobid I, et al. Executive summary of European Task Force document on diagnostic tools in rhinology. Rhinology. 2012;50(4):339–52.PubMed
2.
Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol–Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2007;137(4):555–61.CrossRef
3.
Tomassen P, Newson RB, Hoffmans R, et al. Reliability of EP3OS symptom criteria and nasal endoscopy in the assessment of chronic rhinosinusitis–a GA(2) LEN study. Allergy. 2011;66(4):556–61.PubMedCrossRef
4.
•• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. Supplement. 2012;(23):3 p preceding table of contents, 1-298. Extensive evidence based review of the literature on Rhinosinusitis and including recommendations for management.
5.
• Hellings PW, Fokkens WJ, Akdis C, et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy. 2012. First paper discussing relevance of control in rhinitis and rhinosinusitis.
6.
Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy: J Br Soc Allergy Clin Immunol. 1991;21(1):77–83.CrossRef
7.
Piccirillo JF, Edwards D, Haiduk A, Yonan C, Thawley SE. Psychometric and clinimetric validity of the 31-item Rhinosinusitis Outcome Measure (RSOM-31). Am J Rhinol. 1995;9(6):297–306.CrossRef
8.
9.
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol: Off J ENT-UK; Off J Neth Soc Oto-Rhino-Laryngol Cervico-Fac Surg. 2009;34(5):447–54.CrossRef
10.
Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. The J Allergy Clin Immunol. 1999;104(2 Pt 1):364–9.CrossRef
11.
Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy: J Br SocAllergy Clin Immunol. 2000;30(1):132–40.CrossRef
12.
van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy. 2007;62(12):1359–71.PubMedCrossRef
13.
Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy. 1993;70(3):225–30.PubMed
14.
Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol–Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2004;130(2):157–63.CrossRef
15.
Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. The J Allergy Clin Immunol. 2003;111(3):484–90.CrossRef
16.
Piccirillo JF, Merritt Jr MG, Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol–Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2002;126(1):41–7.CrossRef
17.
• Garbutt J, Spitznagel E, Piccirillo J. Use of the modified SNOT-16 in primary care patients with clinically diagnosed acute rhinosinusitis. Arch Otolaryngol–Head Neck Surg. 2011;137(8):792–7. First available validated QOL questionnaire on acute rhinosinusitis.PubMedCrossRef
18.
Atlas SJ, Gallagher PM, Wu YA, et al. Development and validation of a new health-related quality of life instrument for patients with sinusitis. Qual Life Res: Int J Qual Life Asp Treat, Care Rehabil. 2005;14(5):1375–86.CrossRef
19.
Juniper EF. Measuring health-related quality of life in rhinitis. The J Allergy Clin Immunol. 1997;99(2):S742–9.CrossRef
20.
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8–160.PubMedCrossRef
21.
Vandenplas O, Dramaix M, Joos G, et al. The impact of concomitant rhinitis on asthma-related quality of life and asthma control. Allergy. 2010;65(10):1290–7.PubMedCrossRef
22.
Rechtweg JS, Moinuddin R, Houser SM, Mamikoglu B, Corey JP. Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate. Laryngoscope. 2004;114(5):806–10.PubMedCrossRef
23.
van Agthoven M, Fokkens WJ, van de Merwe JP, Marijke van Bolhuis E, Uyl-de Groot CA, Busschbach JJ. Quality of life of patients with refractory chronic rhinosinusitis: effects of filgrastim treatment. Am J Rhinol. 2001;15(4):231–7.PubMed
24.
Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Am J Rhinol Allergy. 2009;23(4):392–5.PubMedCrossRef
25.
Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol. 2011;120(7):423–7.PubMed
26.
Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol–Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2011;144(3):440–5.CrossRef
27.
Dietz de Loos DAE, Hopkins C, Fokkens W. Symptoms in chronic rhinosinusitis with and without nasal polyps. The Laryngoscope. 2012;123(1):57–63.
28.
Yepes-Nuñes JJ, Bartra J, Muños-Cano R et al. Assessment of nasal obstruction: Correlation between subjective and objective techniques. Allergologia et immunopathologia. Nov 7 2012.
29.
Baiardini I, Braido F, Bindslev-Jensen C, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy. 2011;66(7):840–4.PubMedCrossRef
30.
Georgalas C, Badloe R, van Furth W, Reinartz S, Fokkens WJ. Quality of life in extended endonasal approaches for skull base tumours. Rhinology. 2012;50(3):255–61.PubMed
31.
Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15.PubMedCrossRef
32.
Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. The J Allergy Clin Immunol. 2006;117(3):549–56.CrossRef
33.
• Braido F, Baiardini I, Stagi E, et al. RhinAsthma Patient Perspective: a short daily asthma and rhinitis QoL assessment. Allergy. 2012;67(11):1443–50. A questionnaire of only 8 questions measuring QOL in rhinitis and asthma. Very useful in daily practice.PubMedCrossRef
34.
Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J: J Gen Pract Airways Group. 2011;20(3):257–68.CrossRef
35.
Zhang J, Yu C, Holgate ST, Reiss TF. Variability and lack of predictive ability of asthma end-points in clinical trials. The Eur Respir J: Off J Eur Soc Clin Respir Physiol. 2002;20(5):1102–9.CrossRef
36.
Luskin AT. What the asthma end points we know and love do and do not tell us. The J allergy Clin Immunol. 2005;115(4 Suppl):S539–45.CrossRef
37.
Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA: the J Am Med Assoc. 2001;285(20):2583–93.CrossRef
38.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA: the J Am Med Assoc. 1995;273(1):59–65.CrossRef
Metadata
Title
Disease-Specific Quality-of-Life Questionnaires in Rhinitis and Rhinosinusitis: Review and Evaluation
Authors
Dirk A. E. Dietz de Loos
Christine L. Segboer
Artur Gevorgyan
Wytske J. Fokkens
Publication date
01-04-2013
Publisher
Current Science Inc.
Published in
Current Allergy and Asthma Reports / Issue 2/2013
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-012-0334-8

Other articles of this Issue 2/2013

Current Allergy and Asthma Reports 2/2013 Go to the issue

RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

New Directions in Immunotherapy

SINUSITIS (ML KOWALSKI, SECTION EDITOR)

Nasal Saline Irrigations for the Symptoms of Acute and Chronic Rhinosinusitis

SINUSITIS (ML KOWALSKI, SECTION EDITOR)

Long-Term Successes of Various Sinus Surgeries: A Comprehensive Analysis

RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

Rhinitis in Older Adults

SINUSITIS (ML KOWALSKI, SECTION EDITOR)

Oral Steroid Therapy in Chronic Rhinosinusitis with and without Nasal Polyposis

RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

Fungal Disease of the Nose and Sinuses: An Updated Overview